UK markets open in 4 hours 44 minutes
NIKKEI 225
39,664.92 +491.77 (+1.26%) HANG SENG
18,068.47 -4.43 (-0.02%) CRUDE OIL
81.03 +0.20 (+0.25%) GOLD FUTURES
2,325.80 -5.00 (-0.21%) DOW
39,112.16 -299.05 (-0.76%) Bitcoin GBP
49,123.88 +1,476.53 (+3.10%)
Achieve Life Sciences, Inc. (SP4P.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:14AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 151.99M |
| Enterprise value | 105.95M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.36 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -2.24 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.35 |
| 52-week change 3 | -10.30% |
| S&P500 52-week change 3 | 24.96% |
| 52-week high 3 | 5.3000 |
| 52-week low 3 | 2.8400 |
| 50-day moving average 3 | 4.4631 |
| 200-day moving average 3 | 4.1111 |
Share statistics
| Avg vol (3-month) 3 | 29 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 34.34M |
| Implied shares outstanding 6 | 35.19M |
| Float 8 | 32.53M |
| % held by insiders 1 | 9.69% |
| % held by institutions 1 | 59.40% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 03 Aug 2020 |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -33.93% |
| Return on equity (ttm) | -109.49% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -24.43M |
| Net income avi to common (ttm) | -27.32M |
| Diluted EPS (ttm) | -1.1800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 66.4M |
| Total cash per share (mrq) | 1.93 |
| Total debt (mrq) | 17.19M |
| Total debt/equity (mrq) | 34.77% |
| Current ratio (mrq) | 3.29 |
| Book value per share (mrq) | 1.44 |
Cash flow statement
| Operating cash flow (ttm) | -21.46M |
| Levered free cash flow (ttm) | -13.59M |
© 2024 Yahoo. All rights reserved.